MUSTANG BIO INC's ticker is MBIO and the CUSIP is 62818Q104. A total of 57 filers reported holding MUSTANG BIO INC in Q2 2019. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $38,000 | -45.7% | 37,511 | -11.2% | 0.00% | – |
| Q4 2021 | $70,000 | -35.2% | 42,219 | +5.5% | 0.00% | – |
| Q3 2021 | $108,000 | -21.2% | 40,035 | -3.1% | 0.00% | – |
| Q2 2021 | $137,000 | +25.7% | 41,319 | +25.2% | 0.00% | – |
| Q1 2021 | $109,000 | -20.4% | 33,001 | -8.5% | 0.00% | – |
| Q4 2020 | $137,000 | +185.4% | 36,069 | +135.4% | 0.00% | – |
| Q3 2020 | $48,000 | +9.1% | 15,321 | +10.0% | 0.00% | – |
| Q2 2020 | $44,000 | +76.0% | 13,931 | +48.0% | 0.00% | – |
| Q1 2020 | $25,000 | -37.5% | 9,413 | -5.7% | 0.00% | – |
| Q4 2019 | $40,000 | +60.0% | 9,981 | +23.7% | 0.00% | – |
| Q3 2019 | $25,000 | -62.1% | 8,069 | -56.0% | 0.00% | – |
| Q2 2019 | $66,000 | -4.3% | 18,348 | -11.0% | 0.00% | – |
| Q1 2019 | $69,000 | +13.1% | 20,626 | -3.0% | 0.00% | – |
| Q4 2018 | $61,000 | -85.5% | 21,271 | -70.1% | 0.00% | – |
| Q3 2018 | $422,000 | +5.2% | 71,105 | +21.5% | 0.00% | – |
| Q2 2018 | $401,000 | – | 58,524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 125,000 | $336,000 | 0.45% |
| Spotlight Asset Group, Inc. | 305,312 | $821,000 | 0.41% |
| GSA CAPITAL PARTNERS LLP | 560,215 | $1,507,000 | 0.15% |
| Ikarian Capital, LLC | 506,033 | $1,360,000 | 0.10% |
| EMFO, LLC | 31,000 | $83,000 | 0.07% |
| Bridgewater Advisors Inc. | 45,000 | $121,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 253,275 | $682,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 294,300 | $792,000 | 0.02% |
| TWO SIGMA ADVISERS, LP | 1,235,200 | $3,323,000 | 0.01% |
| Cypress Capital Management LLC (WY) | 2,950 | $8,000 | 0.01% |